Unique DNA transposition into antibodies allows for wider protection against malaria

My first blog on immunology! (About time too…). As always, words in pink are in the glossary.

This post is going to outline the discovery by Tan et al (2016) of a unique type of antibody created by the novel DNA transposition of a gene, which could convey resistance to malaria. The medical significance of this is vast, as it could lead to the development of new vaccines and anti-malarial drugs.

Malaria is a disease caused by the protozoan parasite Plasmodium, that is transmitted by mosquito bites. There are 5 species of Plasmodium that infect humans, the most common and deadly being Plasmodium falciparum, which contributes towards the 500,000 deaths a year that are caused by malaria  [1].

How does the body normally combat infection?

Part of the life cycle of Plasmodium involves reproduction within erythrocytes (red blood cells). During this time, the Plasmodium sticks proteins out of the surface of the erythrocyte, causing the cells to agglutinate and prevent entry into the spleen. These surface proteins are known as antigens. They can be recognised by the host’s immune system and trigger an immune response to remove the parasite. The largest group of malarial antigens are known as RIFINs, and contain ~150 genes.

How does the host detect antigens?

Antigens are detected by B cell antibodies; the soldiers of the adaptive immune system. Antibodies are mobile proteins, each with a binding site that is unique to a specific antigen. When an antibody detects its corresponding antigen, it gets cloned multiple times. These clones tag the protein containing the antigen, which is then detected by the pathogen-removing cells of the immune system. However, Plasmodium has avoided this fate by constantly producing a high number of varied antigens, making it difficult for the immune system to eradicate the parasite.

Newly discovered antibodies allow greater protection against malaria, through wider detection of antigens

This study by Tan et al (2016), discovered two individuals in a donor group that had a large insertion of DNA between the V and DJ segments of the antibody genes. These segments contribute towards the diverse antigen-recognition sites of the antibody. The insertion occurred once in each individual, and was propagated through stimulation and cloning of the antibody after detection of an antigen. The insertion, which was 100 amino acids long, was identified as coding for the collagen-binding LAIR-1 protein found on chromosome 19. The LAIR-1 insert uniquely conveys the ability to bind to a wide range of RIFIN antigens to the antibodies, and removes some of the specificity of regular antibodies.

The LAIR-1 insert had undergone several mutations, which meant it had lost the collagen binding ability and gained the ability to bind RIFIN antigen. These mutations were deemed vital, as artificially removing them prevented the antibodies from binding to RIFIN.

How did this insertion occur?

One proposed mechanism by which this transposition took place is RAG recombination, where enzymes chop out a gene, and transplant it elsewhere in the genome. RAG is used during antibody diversification, to create the wide array of antibodies that can match to any antigen. The target sequences that RAG use to hone in on a gene were found embedded on either side of the insertion, suggesting LAIR-1 had been cut out of chromosome 19, and transplanted into the antibody diversity genes in the ancestral B cell.

To investigate this theory further, Tan et al searched the genome to see if there was a copy of LAIR-1 missing from its usual place on chromosome 19. Chromosomes come in pairs, so if a gene is missing on one of the chromosomes, the functional protein can often still be made by the remaining gene on the other chromosome. However, neither copy of chromosome 19 was missing LAIR-1! So how did this gene mysteriously end up in the middle of an antibody gene sequence?

This gene transposition could have occurred by a previously unknown mechanism. It could also have been facilitated by irregular functioning of gene conversion or AID, both of which are utilised in the generation of antibodies.

Why is this important?

Tan et al speculate that this kind of novel insertion could be more frequent than currently thought, especially in areas which have endemic infection of Plasmodium falciparum. This discovery is undoubtably important, as it could ultimately lead to the development of a vaccine for malaria. It is unknown whether the individuals with these unique antibodies are completely resistant to malaria, but it is very likely that they are substantially more able to remove a persistent infection.

 


 

The paper: Tan et al. A LAIR1 insertion generates broadly reactive antibodies against malaria variant antigens. 2016. Nature. 592(7584): 105-109

[1] http://www.nhs.uk/conditions/Malaria/Pages/Introduction.aspx

Photo by: Flickr user Turkletom

 

 

Advertisements

3 thoughts on “Unique DNA transposition into antibodies allows for wider protection against malaria

  1. Jonny from sci.casual says:

    With all the research going on in CRISPR, I wonder how long (well, after the initial debates on ethics) before we could have a la carte gene editing where we could be immune to malaria or even drastically lower chances of developing AIDS? There was a study some time ago that there was this gene expression in northern Europeans and lower instances of AIDS, but it’s escaping me at the moment…

    Liked by 1 person

    • biologyyak says:

      I’m not sure what gene you mean, but I know there has already been discussion of (if not even actual provisional experiments) to use CRISPR-Cas9 to edit the CCR5 and CXCR4 receptors on T cells and macrophages to increase resistance to HIV. This could be related to the gene you mention, as individuals who have mutations in the CCR5 gene are resistant to HIV infection. I agree that CRISPR-Cas9 has numerous potential uses, many of which probably have not been realised yet, and which will have a profound effect on the future of medicine and human health. I think it will take many years to ascertain the full impact that CRISPR-Cas9 will have on the future of humanity, as it is still a realtively young technology. However, I expect that diseases such as malaria and HIV/AIDS will be some of the first on the list to eradicate, if CRISPR-Cas9 does become a universal gene editing method. I hope to do a post on the advantages, ethics, and future directions of CRISPR soon!

      Like

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s